SUBSCRIBE
SUBSCRIBE

Patient recruitment

PRESS RELEASES
Press Releases
Coya Therapeutics Provides Enrollment Update of the Investigator-Initiated Phase 1 Study of Low Dose Interleukin-2 (LD IL-2) + CTLA4-Ig Fusion Protein in Patients with Frontotemporal Dementia (FTD)
December 18, 2024
 · 
10 min read
Press Releases
Tiziana Life Sciences Announces First Patient with Moderate Alzheimer’s Disease Dosed with Intranasal Foralumab
December 18, 2024
 · 
6 min read
Press Releases
Transpire Bio Achieves Important Corporate Milestone with Completion of First Human Subject Study in the Company’s Asthma and Chronic Obstructive Pulmonary Disease Inhaled Drug Program
December 18, 2024
 · 
1 min read
Press Releases
First-In-Human Study Demonstrates the Potential of the Reprieve System in Patients with Acute Decompensated Heart Failure
December 16, 2024
 · 
5 min read
Press Releases
Lisata Therapeutics Announces Completion of Enrollment in the CENDIFOX Trial
December 10, 2024
 · 
7 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Site Initiation Visit Completed
December 9, 2024
 · 
3 min read
Press Releases
The Multiple Myeloma Research Foundation (MMRF) Announces the First Patient Enrolled in its Horizon Clinical Trials Program to Accelerate the Identification of Optimal Treatment Strategies for Multiple Myeloma
December 5, 2024
 · 
3 min read
Press Releases
Delta-Fly Pharma Inc.: Update for Development Status of DFP-17729
December 5, 2024
 · 
1 min read
Press Releases
SeaStar Medical Activates Sentara Norfolk General Hospital and Provides Enrollment Update in Adult AKI Pivotal Trial
December 4, 2024
 · 
8 min read
Press Releases
Ocular Therapeutix™ Announces More Than 300 Subjects Randomized in SOL-1
December 2, 2024
 · 
11 min read
Press Releases
Delcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Colorectal Cancer
December 2, 2024
 · 
3 min read
Press Releases
RTI Surgical Announces First Patient Enrolled in Investigational Device Exemption (IDE) for Cortiva® Allograft Dermis in Breast Reconstruction
November 25, 2024
 · 
2 min read
Press Releases
BrioHealth Solutions Begins Patient Enrollment in INNOVATE Trial of BrioVAD® System for Advanced Heart Failure
November 25, 2024
 · 
5 min read
Press Releases
Combination of Eflornithine and Lomustine Demonstrates Clinically Meaningful Improvements in Overall Survival (OS) and Progression Free Survival (PFS) in Patients with Recurrent Astrocytoma, IDH Mutant Grade 3
November 25, 2024
 · 
4 min read
Press Releases
SUPIRA MEDICAL INITIATES U.S. EARLY FEASIBILITY STUDY (EFS) FOR HIGH-RISK PCI
November 21, 2024
 · 
2 min read
Press Releases
Foundation for Sarcoidosis Research (FSR) receives confirmation from the Department of Labor (DOL) ensuring patient access to FMLA for participation in clinical trials
November 18, 2024
 · 
4 min read
Press Releases
UPDATE: PredicineCARE™ Liquid Biopsy Assay Featured in NEJM for patient enrollment in Phase III Breast Cancer Trial
November 7, 2024
 · 
2 min read
Press Releases
Angitia Biopharmaceuticals Announces Dosing of First Patient in Phase 2 Clinical Trial of AGA2118 for the Treatment of Osteoporosis
November 5, 2024
 · 
4 min read
Press Releases
Philips enrolls first patient in U.S. clinical trial for innovative integrated single-device to treat peripheral artery disease
November 5, 2024
 · 
5 min read
Press Releases
Oak Hill Bio and Chiesi Group Announce First European Patient Enrolled in the Phase 2b Clinical Study Evaluating OHB-607 for the Prevention of Bronchopulmonary Dysplasia, the Most Common Cause of Chronic Lung Disease in Premature Infants
November 4, 2024
 · 
7 min read
Load More